Daniella Kranjac
Founding GP at Avant Bio
Daniella Kranjac
Founding GP at Avant Bio
New York, New York
Overview
Work Experience
Founding GP
2023 - Current
Board Member
2023
Alpenglow Biosciences is an end-to-end 3D pathology platform that aims to accelerate drug development and improve clinical diagnostics.
Raised $7,600,000.00 from National Institute of Health and Andy Hill Cancer Research Endowment (CARE) Fund.
Board Member
2022
Board Member
2023
Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.
Raised $20,400,000.00 from National Institutes of Health.
Board Member
2019
RoosterBio is a biotechnology company, offers synthetic biology and regenerative medicine.
Raised $40,149,990.00 from Vanedge Capital, Dynamk Capital, Bioeconomy Capital and Dynamk Capital.
Board Member
2023
Vernal Biosciences specializes in high-purity mRNA for research and clinical use.
Raised $41,000,000.00 from Ampersand Capital Partners, Dynamk Capital, Vermont Center for Emerging Technologies, Charles River Laboratories International, Dynamk Capital, Alloy Therapeutics, Ampersand Capital Partners, ATUM and Charles River Laboratories International.
Board Member
2021
Board Observer
2021
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Raised $39,600,000.00 from LabCorp.
Member
2020
Founder & CEO
2015
Strategy and Business Development Consulting for Life Science acquirers, companies, investors and venture funds.